5 completed, 3 unknown, 2 recruiting, 1 terminated. 11 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 5, Unknown 3, Recruiting 2, Terminated 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Universiteit Antwerpen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity Botulinum toxin type A, Dry Needling - Stroke | Phase 2 / Phase 3 | Recruiting | Universiteit Antwerpen | 90 | 2024-09-01 | 2026-05-04 |
| INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder Celecoxib, Minocyclin, Placebo - Major Depressive Disorder, Inflammation | Phase 3 | Recruiting | Universiteit Antwerpen | 240 | 2023-09-21 | 2024-10-15 |
| The DAWN Antivirals Trial for Ambulatory COVID-19 Patients Camostat, Placebo, Molnupiravir - Covid19, SARS-CoV Infection | Phase 3 | Terminated | KU Leuven | 44 | 2021-06-15 | 2022-10-03 |
| Metformin as RenoProtector of Progressive Kidney Disease Metformin Hydrochloride, Placebo Oral Tablet - Chronic Kidney Diseases | Phase 3 | Unknown | Universiteit Antwerpen | 290 | 2019-11-05 | 2023-12-19 |
| Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania Dihydroartemisinin-piperaquine, Artesunate-amodiaquine - Malaria,Falciparum, Anemia | Phase 3 | Completed | National Institute for Medical Research, Tanzania | 1555 | 2019-03-26 | 2024-11-20 |
| A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts AV2-SA2, SA - Cutaneous Warts | Phase 2 / Phase 3 | Completed | Universiteit Antwerpen | 260 | 2018-01-01 | 2023-05-17 |
| Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer HAI-90Y radioembolization (SIR-spheres injection), systemic chemotherapy LV5FU2 - Colorectal Cancer | Phase 3 | Unknown | Universiteit Antwerpen | 162 | 2013-08-01 | 2017-07-07 |
| Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren Sulfadoxine-pyrimethamine, Piperaquine, Albendazole - Healthy | Phase 3 | Completed | Universiteit Antwerpen | 616 | 2012-11-01 | 2014-02-04 |
| Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria Artemether/Lumefantrine, Artesunate/Amodiaquine, Quinine + Clindamycin - Malaria | Phase 3 | Completed | Universiteit Antwerpen | 2117 | 2012-05-01 | 2014-10-22 |
| The Effect of an Aerobic Exercise Programme in Stroke Patients Aerobic exercise group, Control group, Follow-up first aerobic exercise group - Cerebrovascular Accident | Phase 3 | Unknown | University College of Antwerp | 50 | 2010-02-01 | 2010-04-14 |
| Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) cisplatin + docetaxel, cisplatin + docetaxel + enoxaparin - Non-Small Cell Lung Cancer | Phase 3 | Completed | University Hospital, Antwerp | 104 | 2008-06-01 | 2013-06-28 |
Malaria (3) · Stroke (2) · Anemia (1) · COVID-19 (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Depressive Disorder, Major (1) · Inflammation (1) · Malaria, Falciparum (1) · Renal Insufficiency, Chronic (1) · Schistosomiasis (1) · Severe Acute Respiratory Syndrome (1) · cyclopia sequence (1)
amodiaquine, artesunate drug combination (2) · Albendazole (1) · Artemether, Lumefantrine Drug Combination (1) · Botulinum Toxins, Type A (1) · Celecoxib (1) · Cisplatin (1) · Clindamycin (1) · Control Groups (1) · Docetaxel (1) · Dry Needling (1) · Enoxaparin (1) · Fluorouracil (1) · Heparin, Low-Molecular-Weight (1) · Levoleucovorin (1) · Metformin (1)
Belgium (8) · Republic of the Congo (2) · Canada (1) · Spain (1) · Tanzania (1) · Uganda (1)
Carolyn Nabasumba, M.B.Ch.B (1) · Dirk Vissers, dr. (1) · Hilde Feys, prof.dr. (1) · Hypolite M. Mavoko, MD MPH (1) · Joachim Doua, MD (1) · John PA Lusingu, MD, PhD (1) · Junior Matangila, MD (1) · Manuel Morrens, MD PhD (1) · Marc Peeters (1) · Marc Van den Eynde (1) · Pablo Herrero Gallego, PhD (1) · Pascal Lutumba, MD PhD (1) · Patrick Cras, prof. dr. (1)
PMID 24059911, PMID 24063608, PMID 27280792, PMID 27840069, PMID 28284834, PMID 29105516, PMID 32382685, PMID 33337539, PMID 34184251, PMID 37474234, PMID 37840107, PMID 38837240, PMID 39350954, PMID 40804388, PMID 42160369